Alzheimer's researchers link glucose metabolism to disease pathology, uncovering new drug targets

Much of the Alzheimer’s disease research over the past several years has focused on the proteins amyloid and tau, which are known to clump up in the brain and are thought to be the cause of memory loss and other telltale symptoms. But a new study, born from a collaborative effort among research centers across the country, suggests that other proteins may play a role in Alzheimer’s—and they could offer new druggable targets.